Bruker Corporation (BRKR)

Market Cap	10.71B
Revenue (ttm)	2.96B
Net Income (ttm)	427.20M
Shares Out	137.67M
EPS (ttm)	2.90
PE Ratio	26.81
Forward PE	27.75
Dividend	$0.20 (0.26%)
Ex-Dividend Date	Feb 29, 2024

Volume	1,156,604
Open	79.10
Previous Close	78.56
Day's Range	77.28 - 79.45
52-Week Range	53.79 - 94.86
Beta	1.18
Analysts	Buy
Price Target	85.67 (+10.17%)
Earnings Date	May 2, 2024

About BRKR

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related te...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 4, 2000
• Employees: 9,707
• Stock Exchange: NASDAQ
• Ticker Symbol: BRKR

Financial Performance

In 2023, Bruker's revenue was $2.96 billion, an increase of 17.14% compared to the previous year's $2.53 billion. Earnings were $427.20 million, an increase of 44.03%.

Analyst Forecast

According to 7 analysts, the average rating for BRKR stock is "Buy." The 12-month stock price forecast is $85.67, which is an increase of 10.17% from the latest price.

Price Target

$85.67

(10.17% upside)

Analyst Consensus: Buy